Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tocilizumab Long-term Extension in RA
NCT00144547Phase 3Completed
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Apr 2004
- Primary completion
- Aug 2008
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
01
Overview
A Phase 3 trial of tocilizumab in rheumatoid arthritis (RA), sponsored by Chugai Pharmaceutical Co., Ltd.. Started Apr 2004; status: completed.
02
Drugs
tocilizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00144547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00144547.